Skip to main content
. 2018 Sep 10;2018:bcr2018224611. doi: 10.1136/bcr-2018-224611

Table 3.

Roussel Uclaf Causality Assessment Method for drug-induced liver injury/herb-induced liver injury hepatocellular injury*

Points Case report
Time to onset from beginning of drug/herb 5–90 days (re-challenge: 1–15 days) 2
<5 or >90 days (re-challenge: >15 days) 1 X
Time to onset from cessation of drug/herb ≤15 days (except for slowly metabolised chemicals >15 days) 1
Course of ALT after cessation of drug/herb
(% difference between ALT peak and N)
Decrease ≥50% within 8 days 3
Decrease ≥50% within 30 days 2 X
No information or continued drug use 0
Decrease ≥50% after the 30th day 0
Decrease <50% after the 30th day or recurrent increase −2
Risk factors Alcohol use—presence 1
Alcohol use—absence 0 X
Age ≥55 years 1 X
Age <55 years 0
Concomitant drug(s)/herb(s) None or no information 0
Concomitant drug/herb with incompatible time to onset 0 X
Concomitant drug/herb with compatible or suggestive time to onset −1
Concomitant drug/herb known as hepatotoxin and with compatible or suggestive time to onset −2
Concomitant drug/herb with evidence for its role in this case (positive rechallenge or validated test) −3
Search for alternative causes† All causes reasonably ruled out (group I and II) 2 X
Six causes of group I ruled out 1
4–5 causes of group I ruled out 0
<4 causes of group I ruled out −2
Alternative cause highly probable −3
Previous hepatotoxicity of drug/herb Reaction labelled in the product characteristics 2
Reaction published but unlabelled 1 X
Reaction unknown 0
Response to unintended re-exposure Doubling of ALT with drug/herb alone, (if ALT <5N before re-exposure) 3
Doubling of ALT with drug/herb already given at time of first reaction 1
Increase of ALT but <5N in the same conditions as for first administration −2
Other situations 0
Total 7‡

*Adapted from Danan and Benichou.22

†Group I causes: HAV, HBV, HCV, biliary obstruction (imaging), alcoholism, acute recent hypotension.

Group II causes: complications of underlying disease (eg, sepsis), CMV, EBV, HSV.

‡≤0, excluded causality; 1 – 2, unlikely; 3 – 5, possible; 6 – 8, probable; ≥ 9, highly probable.

ALT, alanine transaminase; CMV, cytomegalovirus; EBV; Epstein Barr virus; HAV, hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HSV, herpes simplex virus.